Fundraising FoxViamet Pharmaceuticals, Inc
4 known investors
Find your way into Viamet Pharmaceuticals, Inc
Sign up to see every warm intro you have to Viamet Pharmaceuticals, Inc
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Viamet Pharmaceuticals, Inc team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Viamet provides a resource for people to organize questions and conduct research about medical travel, provider verification, care coordination, and health-related travel planning. The platform helps users compare options and think through decisions before committing resources to medical tourism or wellness travel projects.
Investors · 4
Astellas Venture Management LLClisted by Astellas Venture Management LLCSouth San Francisco · $200K – $5M
How we know: Astellas Venture Management LLC's portfolio page · Not right? Tell us
Hatteras Venture PartnersreportedResearch Triangle · $500K – $4M
How we know: funding news · Not right? Tell us
Lilly Venturesreported
How we know: funding news · Not right? Tell us
Novartis Venture FundreportedBasel · $5M – $25M
How we know: funding news · Not right? Tell us
Frequently asked questions
- What does Viamet Pharmaceuticals, Inc do?
- Viamet provides a resource for people to organize questions and conduct research about medical travel, provider verification, care coordination, and health-related travel planning. The platform helps users compare options and think through decisions before committing resources to medical tourism or wellness travel projects.
- Who are Viamet Pharmaceuticals, Inc's investors?
- Viamet Pharmaceuticals, Inc's investors include Astellas Venture Management LLC, Hatteras Venture Partners, Lilly Ventures, Novartis Venture Fund.